Reversing Dysfunctional Dendritic Cells in Breast Cancer
Author Information
Author(s): Satthaporn Sukchai, Aloysius Mark M, Robins Richard A, Verma Chandan, Chuthapisith Suebwong, Mckechnie Alasdair J, El-Sheemy Mohamad, Vassanasiri Wichai, Valerio David, Clark David, Jibril Jibril A, Eremin Oleg
Primary Institution: Queen's Medical Centre, Nottingham University Hospitals, Nottingham, UK
Hypothesis
Can ex vivo culturing of monocytes with specific cytokines restore the function of dendritic cells in breast cancer patients?
Conclusion
Dendritic cells from breast cancer patients can be effectively activated and restored to functionality through specific cytokine treatments.
Supporting Evidence
- Dendritic cells from breast cancer patients were found to be dysfunctional and anergic.
- Using a combination of GM-CSF, IL-4, TNF-α, and IFN-α significantly improved dendritic cell recovery and function.
- Enhanced expression of HLA-DR and CD86 was observed in dendritic cells cultured with the 4 cytokine combination.
- Dendritic cells generated with IFN-α showed increased ability to stimulate T cell responses.
- IL-12p40 production was significantly higher in dendritic cells treated with the 4 cytokine combination.
Takeaway
Doctors found a way to help special immune cells called dendritic cells work better in breast cancer patients by using a mix of helpful proteins.
Methodology
Monocytes from breast cancer patients were cultured with different combinations of cytokines to assess their ability to mature into functional dendritic cells.
Participant Demographics
Patients with operable breast cancer, aged not specified.
Statistical Information
P-Value
p < 0.001
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website